Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
May 10 2024 - 5:14AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
Washington, D.C. 20549
_____________________
FORM 6-K
_____________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Date: May 10, 2024
Commission File Number: 001-37835
________________________________________
Indivior PLC
________________________________________
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
_______________________________
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ☐
EXHIBIT INDEX
Exhibit
No.
|
Description
of Exhibit
|
99.1
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
Indivior PLC
|
Date: May 10,
2024
|
/s/
Kathryn Hudson
|
|
Name:
Kathryn Hudson
|
|
Title:
Company Secretary
|
Exhibit
99.1
Indivior PLC - Board Committee Changes
Slough, UK and Richmond, VA, May 10, 2024 - Indivior PLC announces that Dr. David
Wheadon, who will join the Board as an Independent Non-Executive
Director on June 1, 2024, has been appointed as a member of the
Nomination, Remuneration and Science Committees also with effect
from June 1, 2024.
Furthermore, in order to comply with Nasdaq's listing rule that
requires the Nomination Committee be comprised solely of
Independent Directors, Jerome Lande has advised the Board that he
will step down as a member of the Nomination Committee with effect
from May 31, 2024. Mr. Lande is a Representative Director of Scopia
Capital Management LP, who are a significant shareholder of the
Group.
Following these changes, the membership of the Nomination,
Remuneration and Science Committees will be as
follows:
Nomination Committee
Graham Hetherington (Chair)
Peter Bains
Joanna Le Couilliard
Dr. Keith Humphreys
Barbara Ryan
Mark Stejbach
Juliet Thompson
Dr. David Wheadon
Remuneration Committee
Joanna Le Couilliard (Chair)
Peter Bains
Graham Hetherington
Barbara Ryan
Dr. David Wheadon
Science Committee
Peter Bains (Chair)
Dr. Keith Humphreys
Barbara Ryan
Mark Stejbach
Dr. David Wheadon
This announcement is made in accordance with Listing Rule
9.6.11.
Kathryn Hudson
Company Secretary
Indivior PLC's Legal Entity Identifier code is
213800V3NCQTY7IED471.
Indivior (PK) (USOTC:IZQVF)
Historical Stock Chart
From May 2024 to Jun 2024
Indivior (PK) (USOTC:IZQVF)
Historical Stock Chart
From Jun 2023 to Jun 2024